- An open-label, single-arm phase II clinical study of docetaxel plus lobaplatin for Chinese patients with pulmonary and hepatic metastasis of nasopharyngeal carcinoma
Shuai Zhang et al, 2016, Anti-Cancer Drugs CrossRef - Emerging Trends in Metal‐based Anticancer Agents: Drug Design to Clinical Trials and their Mechanism of Action
Achamo Temesgen et al, 2023, ChemistrySelect CrossRef - Metal-based Complexes as Potential Anti-cancer Agents
Sabyasachi Banerjee et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef - Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center
H.-T. Wu et al, 2016, European Journal of Surgical Oncology (EJSO) CrossRef - Lobaplatin Inhibits Prostate Cancer Proliferation and Migration Through Regulation of BCL2 and BAX
Hongwen Cao et al, 2019, Dose-Response CrossRef - An overview on ligands of therapeutically interest
Julia Martín, 2018, Pharmacy & Pharmacology International Journal CrossRef - A randomized and open-label phase II trial reports the efficacy of neoadjuvant lobaplatin in breast cancer
Xiujuan Wu et al, 2018, Nature Communications CrossRef - Evaluation of Antiproliferative Palladium(II) Complexes of Synthetic Bisdemethoxycurcumin towards In Vitro Cytotoxicity and Molecular Docking on DNA Sequence
Natalia Miklášová et al, 2021, Molecules CrossRef - Dose Escalation of Lobaplatin Concurrent with IMRT for the Treatment of Stage III-IVb NPC: A Phase I Clinical Trial
Si-Yang Wang et al, 2018, Translational Oncology CrossRef - Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies
Hai-Tao Wu et al, 2016, World Journal of Surgical Oncology CrossRef - Lobaplatin-based regimens outperform cisplatin for metastatic breast cancer after anthracyclines and taxanes treatment
Zhipeng Wang et al, 2018, Saudi Journal of Biological Sciences CrossRef - Inorganic Coordination Chemistry: Where We Stand in Cancer Treatment?
Pedro Pedrosa et al, 2018, Basic Concepts Viewed from Frontier in Inorganic Coordination Chemistry CrossRef - Comparison of the short‐term efficacy and serum markers between lobaplatin/paclitaxel‐ And carboplatin/paclitaxel‐based adjuvant chemotherapy in patient with ovarian cancer
Wei Wang et al, 2021, Journal of Clinical Pharmacy and Therapeutics CrossRef - Metallo-Drugs in Cancer Therapy: Past, Present and Future
Roxana Liana Lucaciu et al, 2022, Molecules CrossRef - Pharmacokinetics and safety of lobaplatin plus etoposide in Chinese men older than 65 years with extensive-stage small cell lung cancer: a phase II clinical trial
Jianhua Chen et al, 2019, Cancer Chemotherapy and Pharmacology CrossRef - Advances in Metallodrug‐Driven Combination Therapy for Treatment of Cancer
Rishabha Malviya et al, 2023, Multi‐Drug Resistance in Cancer CrossRef - Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer
Fenghu Li et al, 2019, Medicine CrossRef - Simultaneous quantitation of two diastereoisomers of lobaplatin in rat plasma by supercritical fluid chromatography with tandem mass spectrometry and its application to a pharmacokinetic study
Xiangjun Meng et al, 2015, Journal of Separation Science CrossRef - Drimia calcarata Bulb Extracts Deactivate the PI3K Signalling Pathway in Cervical HPV-18 Positive HeLa Cells
Kagiso Laka et al, 2022, Clinical Complementary Medicine and Pharmacology CrossRef